Philip Morris sells asthma inhaler company, citing ‘unwarranted opposition’ to its goals
Friday, 20 September 2024 ()
Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.
|
||||
You Might Like |
||||
